ArticleRheumatology international2025
Social media landscape of rheumatology journals.
Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Social media platforms for ethical post-publication promotion.Clinical rheumatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSocial media (SoMe) platforms provide ample opportunities for disseminating research results and journal updates. The presence of indexed rheumatology journals on SoMe has been scarcely explored.
objectivesThe purpose of this study is to assess the presence of mainstream rheumatology journals on key SoMe platforms and to analyze the relationship between bibliometric indicators and alternative metrics.
methodsQuantitative data were collected from the SCImago Journal and Country Rank platform. The availability of journal SoMe channels (X, Facebook, YouTube), number of subscribers, and activity indicators were analyzed. Bibliometric indicators, including values of journal Hirsch index, SCImago Journal Rank (SJR), journal quartile ranking based on SJR, total number of publications and citations over the past three years, as well as the region and publication mode (open access) were analyzed. The association between SoMe metrics and bibliometric indicators was assessed using Spearman's rank correlation coefficient (ρ).
resultsAmong the analyzed 76 rheumatology journals, 29 (38.2%) had an official SoMe account. X (formerly Twitter) turned out to be the most frequently used platform - 28 (96.5%), followed by Facebook - 12 (15.8%), and YouTube 5 (6.6%). SJR and number of followers on X positively correlated (ρ = 0.594, P = 0.001). The number of Facebook followers also showed a positive correlation with SJR (ρ = 0.587, P = 0.045). Only five journals had YouTube channels with a total of 2,471 subscribers, 272 videos, and 288,530 views. The Annals of the Rheumatic Diseases had the most popular YouTube channel, with 1,130 subscribers and 170,575 views.
conclusionSoMe channels are crucial for promotion of rheumatology journals. The prominence of the X channels points to their crucial role in disseminating journal updates and boosting their alternative impact metrics.
Indexed as
Identifiers
40892226What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.